BioSpace News Archive

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the design of a new Phase 2 clinical trial of TNX-1300 (T172R/G173Q double-mutant cocaine esterase 200 mg, i.v. solution) for the treatment of cocaine intoxication.

Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced the presentation of an analysis from its Phase 2a BALANCED study of efruxifermin (EFX) in patients with biopsy-confirmed F1-F3 fibrosis associated with non-alcoholic steatohepatitis (NASH).

Basilea Pharmaceutica Ltd, a commercial-stage biopharmaceutical company, announced an update on the progress made in the implementation of its strategic focus on anti-infectives.

Ipsen and Epizyme announced that they have entered into a definitive merger agreement under which Ipsen will acquire Epizyme.

Hemogenyx Pharmaceuticals plc is pleased to announce that Dr Vladislav Sandler, Chief Executive Officer & Co-Founder of Hemogenyx Pharmaceuticals, will host a live investor webinar on 6 July 2022 at 16:00 BST at which he will present an overview of the Company’s activities and immediate future directions of its work, and will answer questions about the Company’s current activities.

Wilmington, Delaware, United States: Endoscopy-related infections are a worldwide concern for healthcare industry, with emergent risks propelling the need for robust processing protocols.

Wilmington, Delaware, United States: According to the report, the global glycomics market was valued at US$ 0.9 Bn in 2020 and is projected to expand at a CAGR of 11.2% from 2021 to 2031.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global surgical mesh market is estimated to exceed a valuation of US$ 1.29 Bn in 2022, and expand at a significant CAGR of 5.5% by value over the assessment period.

Wilmington, Delaware, United States: A sterilant is a sterilizing agent used by the medical industry to inactivate or destroy various types of microorganisms present in surgical instruments and medical supplies.

Immunovia will present PanFAM-1 results , June 27, 2022 at 13:00 pm CET. Analysts, investors and media are invited to a webcast and teleconference.